Zai Lab Ltd: Unternehmensprofil, Finanzberichte & Marktperformance

mehr Informationen über Zai Lab Ltd Unternehmen

Zai Lab Ltd is a holding company primarily engaged in biopharmaceuticals. The Company is committed to addressing the unmet medical needs in the fields of tumors, autoimmune diseases, infectious diseases and central nervous system diseases through product discovery, development and commercialization. The Company has a series of patented drug candidates from the discovery stage to the late clinical project. These include ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others.

Zai Lab Ltd Informationen



BörsenkürzelZLAB

Name des UnternehmensZai Lab Ltd

IPO-datumSep 28, 2020

CEODu (Ying)

Anzahl der mitarbeiter1869

WertpapierartDepository Receipt

GeschäftsjahresendeSep 28

AddresseBuilding B, 899 Halei Road, Pudong

StadtSHANGHAI

BörseNASDAQ OMX - NASDAQ BASIC

LandChina

Postleitzahl201203

Telefon862161632588

Websitehttps://www.zailaboratory.com/

BörsenkürzelZLAB

IPO-datumSep 28, 2020

CEODu (Ying)

Führungskräfte von Zai Lab Ltd



Name

Name/Position

Position

Aktienbesitz

Veränderung

Dr. John David Diekman, Ph.D.

Lead Independent Director

99.77K

+10831.00%

Mr. Joshua L. Smiley

President, Chief Operating Officer

86.60K

+10000.00%

Mr. William David (Bill) Lis

Independent Director

35.11K

-2983.00%

Dr. Yajing Chen, Ph.D.

Chief Financial Officer

17.44K

-240.00%

Dr. Ying (Samantha) Du, Ph.D.

Chairman of the Board, Chief Executive Officer, Co-Founder

--

Ms. Leung (Nisa Bernice) Wing-Yu

Independent Director

--

Mr. Peter Karl Wirth, J.D.

Independent Director

--

Mr. Leon Oliver (Lonnie) Moulder, Jr.

Independent Director

--

Mr. Frazor Titus Edmondson, J.D.

Company Secretary, Chief Legal Officer

--

Mr. Scott W. Morrison, CPA

Independent Director

--

Name

Name/Position

Position

Aktienbesitz

Veränderung

Dr. John David Diekman, Ph.D.

Lead Independent Director

99.77K

+10831.00%

Mr. Joshua L. Smiley

President, Chief Operating Officer

86.60K

+10000.00%

Mr. William David (Bill) Lis

Independent Director

35.11K

-2983.00%

Dr. Yajing Chen, Ph.D.

Chief Financial Officer

17.44K

-240.00%

Dr. Ying (Samantha) Du, Ph.D.

Chairman of the Board, Chief Executive Officer, Co-Founder

--

Ms. Leung (Nisa Bernice) Wing-Yu

Independent Director

--

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

ZEJULA

42.43M

36.78%

VYVGART

27.73M

24.03%

NUZYRA

15.43M

13.38%

Optune

12.66M

10.97%

QINLOCK

8.90M

7.72%

Andere

8.21M

7.12%

Nach RegionUSD

Name

Umsatz

Anteil

China (Mainland)

116.09M

0.00%

Nach Geschäftsbereich

Nach Region

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

ZEJULA

42.43M

36.78%

VYVGART

27.73M

24.03%

NUZYRA

15.43M

13.38%

Optune

12.66M

10.97%

QINLOCK

8.90M

7.72%

Andere

8.21M

7.12%

Aktionärsstatistik

Aktualisiert: Sat, Feb 7

Aktionäre

Aktionärstypen

Aktionäre

Anteil

Capital World Investors

5.39%

Fidelity Management & Research Company LLC

3.79%

Norges Bank Investment Management (NBIM)

3.41%

ClearBridge Investments, LLC

3.12%

RTW Investments L.P.

2.03%

Andere

82.26%

Aktionäre

Anteil

Capital World Investors

5.39%

Fidelity Management & Research Company LLC

3.79%

Norges Bank Investment Management (NBIM)

3.41%

ClearBridge Investments, LLC

3.12%

RTW Investments L.P.

2.03%

Andere

82.26%

Aktionärstypen

Aktionäre

Anteil

Investment Advisor

15.68%

Investment Advisor/Hedge Fund

12.47%

Sovereign Wealth Fund

3.58%

Hedge Fund

2.94%

Individual Investor

1.78%

Private Equity

1.44%

Venture Capital

1.12%

Research Firm

0.61%

Pension Fund

0.02%

Andere

60.34%

Institutionelle Beteiligung



Aktualisiert: Wed, Jan 21

Berichtszeitraum

Anzahl der Institutionen

Gehaltenen Aktien

Anteil

Veränderung

2026Q4

280

37.42M

42.38%

--

2025Q4

369

40.92M

36.54%

-16.68M

2025Q3

372

46.61M

41.70%

-15.37M

2025Q2

394

60.58M

54.15%

-11.96M

2025Q1

453

59.51M

53.68%

-14.18M

2024Q4

446

60.80M

55.47%

-4.29M

2024Q3

439

51.45M

51.99%

-10.14M

2024Q2

454

47.04M

47.66%

-14.67M

2024Q1

465

46.22M

46.47%

-13.77M

2023Q4

497

46.31M

46.92%

-16.57M

Aktionärsaktivitäten



Name

Gehaltenen Aktien

Anteil

Veränderung

Änderung%

Datum

Capital World Investors

6.08M

5.43%

+41.48K

+0.69%

Sep 30, 2025

Fidelity Management & Research Company LLC

4.28M

3.82%

-610.67K

-12.50%

Sep 30, 2025

ClearBridge Investments, LLC

3.52M

3.14%

-492.62K

-12.28%

Sep 30, 2025

RTW Investments L.P.

2.29M

2.05%

-3.25M

-58.62%

Sep 30, 2025

Janus Henderson Investors

2.05M

1.83%

-148.32K

-6.75%

Sep 30, 2025

Wellington Management Company, LLP

1.72M

1.53%

+341.49K

+24.80%

Sep 30, 2025

Frazier Life Sciences Management, L.P.

1.63M

1.45%

+319.18K

+24.40%

Sep 30, 2025

Baron Capital Management, Inc.

1.37M

1.22%

-216.57K

-13.64%

Sep 30, 2025

Verbundene ETFs



Aktualisiert: Sat, Dec 6

Name

Anteil

Tema Oncology ETF

1.67%

ALPS Medical Breakthroughs ETF

1.19%

Virtus LifeSci Biotech Products ETF

0.97%

Invesco Golden Dragon China ETF

0.58%

National Security Emerging Markets Index ETF

0.39%

iShares Biotechnology ETF

0.18%

Capital Group New Geography Equity ETF

0.15%

ProShares Ultra Nasdaq Biotechnology

0.12%

Invesco Nasdaq Biotechnology ETF

0.12%

ActivePassive International Equity ETF

0.03%

Tema Oncology ETF

Anteil1.67%

ALPS Medical Breakthroughs ETF

Anteil1.19%

Virtus LifeSci Biotech Products ETF

Anteil0.97%

Invesco Golden Dragon China ETF

Anteil0.58%

National Security Emerging Markets Index ETF

Anteil0.39%

iShares Biotechnology ETF

Anteil0.18%

Capital Group New Geography Equity ETF

Anteil0.15%

ProShares Ultra Nasdaq Biotechnology

Anteil0.12%

Invesco Nasdaq Biotechnology ETF

Anteil0.12%

ActivePassive International Equity ETF

Anteil0.03%

Dividende



In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.

Datum

Dividende

Stichtag für die Aktienregistrierung

Zahltag

Ex-Dividendentag

Keine Daten

Aktien-Split



Datum

Ex-Dividendentag

Art

Verhältnis

Keine Daten

Datum

Ex-Dividendentag

Art

Verhältnis

Keine Daten